Document is current
Any future updates will be listed below
-
Authors
Tetens, Malte M. https://orcid.org/0000-0002-6464-8944
Roed, Casper
Bodilsen, Jacob
Omland, Lars H.
Mens, Helene
Lebech, Anne-Mette
Obel, Niels
Møller, Kirsten
Rasmussen, Rune
Overgaard-Steensen, Christian
Perner, Anders
Ziebell, Morten
Andersen, Åse B.
-
Funding
Funding for this research was provided by:
The Research Fund of Copenhagen University Hospital - Rigshospitalet
National Hospital
- License Information
-
More Information
Article History
Received: 11 March 2024
Accepted: 1 July 2024
First Online: 9 July 2024
Declarations
:
: This study was approved by the Danish Board of Health (record numbers 3–3013-2579/1 and 3–3013-3168/1). Patient consent or permission from an ethical committee is not required for this type of study in Denmark. All data is managed in compliance with relevant data protection and privacy regulations and in accordance with the Helsinki declaration.
: MMT has received travel grants outside this work from GlaxoSmithKline Pharma A/S. AML reports speakers’ honorarium/travel grants/advisory board activity and unrestricted grant from Gilead, speakers honorarium /travel grants from GSK, speaker’s honorarium/advisory board activity from Pfizer outside this work. AP reports honorarium for advisory board work at Novartis. None of the authors report any conflict of interests in connection with this article.
: We adhered to the STROBE Statement checklist when we prepared this manuscript.
: We adhered to Neurocritical Care’s instruction for authors when we prepared this manuscript.
